The above results suggest that upregulation of KDM6B expression enhances CD8+ T-cell infiltration in colorectal tumor tissues and potentiates the therapeutic efficacy of immune checkpoint inhibitors. This evidence concerns the gene KDM6B and colorectal neoplasm.